Testing effectiveness (Phase 2)Ended earlyNCT01545141
What this trial is testing
Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer
Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Tumors+1 more
Roswell Park Cancer Institute 15